Crossmark

Variant rs10911021 that associates with coronary heart disease in type 2 diabetes, is associated with lower concentrations of circulating HDL cholesterol and large HDL particles but not with amino acids

Crossref DOI link: https://doi.org/10.1186/s12933-016-0435-0

Published Online: 2016-08-22

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Beaney, Katherine E.

Cooper, Jackie A.

McLachlan, Stela

Wannamethee, S. Goya

Jefferis, Barbara J.

Whincup, Peter

Ben-Shlomo, Yoav

Price, Jacqueline F.

Kumari, Meena

Wong, Andrew

Ong, Ken

Hardy, Rebecca

Kuh, Diana

Kivimaki, Mika

Kangas, Antti J.

Soininen, Pasi

Ala-Korpela, Mika

Drenos, Fotios

Humphries, Steve E.
Funding

Funding for this research was provided by:

British Heart Foundation (RG/10/12/28456, RG/13/16/30528, RG/07/008/23674, RG/98002, BHF PG08/008, BHF PG08/008, BHF PG08/008)

Medical Research Council (K013351, ID85374, MC_UU_12019/1, 1270920, MC_UU_12013/1-9)

Stroke Association

National Heart and Lung Institute (HL036310)

National Institute on Aging (5RO1AG13196, AG1764406S1)

Agency for Health Care Policy and Research (HS06516)

John D. and Catherine T. MacArthur Foundation Research Networks on Successful Midlife Development and Socioeconomic Status and Health

Department of Health Policy Research Programme

Chief Scientist Office of Scotland (CZB/4/672)

Pfizer

Diabetes UK (10/0003985)

Sigrid Juséliuksen Säätiö

Strategic Research Funding, University of Oulu
License Information

Text and Data Mining valid from 2016-08-22

Version of Record valid from 2016-08-22
More Information

Article History

Received: 14 June 2016

Accepted: 10 August 2016

First Online: 22 August 2016

Document is current

Any future updates will be listed below